BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Acambis PLC 

Peterhouse Technology Park
100 Fulbourn Road
Cambridge    CB19PT  United Kingdom
Phone: 44-1223-275300 Fax: 44-1223-416300


SEARCH JOBS




Industry
Biotechnology






 Company News
Sanofi-Aventis (France) (SASY.PA) to Buy Vaccine Maker Acambis PLC (ACAM) (JOBS) for $548 Million 7/25/2008 11:39:05 AM    More...
Acambis PLC (ACAM) Wins $425M US Smallpox Vaccine Contract 4/23/2008 7:08:14 AM    More...
Acambis PLC (ACAM) Extends Sanofi Pasteur (SASY.PA) Licensing Agreement for ChimeriVax-JE Vaccine 3/20/2008 7:16:02 AM    More...
Acambis PLC (ACAM) Initiates Pre-Clinical Testing with Herpes Vaccine from Harvard Medical School 2/25/2008 10:53:43 AM    More...
Acambis PLC (ACAM) Welcomes US Department of Defense's Transition to ACAM2000(TM) as Its Only Smallpox Vaccine 2/15/2008 1:09:41 PM    More...
Acambis PLC (ACAM) Welcomes US Department of Defense's Transition to ACAM2000(TM) as Its Only Smallpox Vaccine 2/14/2008 10:10:34 AM    More...
Positive Phase I and Pre-Clinical Data Suggest Acambis PLC (ACAM)'s M2e-Based Universal Influenza Vaccine, ACAM-FLU-A(TM), Could Tackle Influenza Pandemics 1/3/2008 10:26:24 AM    More...
Acambis PLC (ACAM) Delivers ACAM2000(TM) Doses to US Government; Increases 2007 Revenue Expectations 1/3/2008 9:23:59 AM    More...
Acambis PLC (ACAM) Reports Positive Data from Trials of Universal Influenza A Vaccine 1/3/2008 9:19:54 AM    More...
Acambis PLC (ACAM) Concludes C. difficile Vaccine Formulation Work on Schedule and Will Commence Proof-of-Concept trial in 2008 12/18/2007 1:27:00 PM    More...
12345678910...